From Manchester to Toronto – Improving lupus ‘brain fog’

Lupus Canada proudly supports Dr. Barraclough and Dr. Touma’s study, Cognitive Dysfunction and Fatigue in Systemic Lupus Erythematosus, through our 2021 Catalyst Grant. To learn more about the grant recipients and their project please visit https://www.lupus.org/2021-recipients-of-the-lupus-canada-catalyst-award.

In early 2021, Dr. Michelle Barraclough, Research Associate for Manchester BRC’s Musculoskeletal theme, began a year-long research placement in Toronto to better understand ‘brain fog’ in lupus patients.

She shares her progress to date, and how this trans-Atlantic collaboration aims to improve care and treatments for patients. To read the full article please visit https://www.manchesterbrc.nihr.ac.uk/news-and-events/manchester-to-toronto-improving-lupus-brain-fog

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Anifrolumab (Saphnelo) listed in SK

Read

Belimumab (Benlysta) listed in AB, NL & NIHB

Read

Belimumab (Benlysta) listed in ON

Read